Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.

Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedRemoved the 403 Forbidden content and the Home link from the page, effectively eliminating the access-denied snippet and its navigation element from the visible content.SummaryDifference0.5%

- Check23 days agoChange DetectedThe study page now displays a 403 Forbidden error for the NCT03025308 record, replacing the expected content with an access-restricted error screen.SummaryDifference16%

- Check30 days agoChange DetectedThe page now shows Revision: v3.7.0, indicating an updated document version. It replaces the prior Revision: v3.6.6.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded related topics entries under the MedlinePlus Genetics section, including Rheumatoid arthritis and MedlinePlus Genetics as related topics. This expands the page’s related topics area to surface broader RA and genetics context for readers.SummaryDifference0.0%

- Check44 days agoChange DetectedA new revision tag v3.6.6 was added and the previous tag v3.6.5 was removed, indicating a minor internal version update to the page's underlying system.SummaryDifference0.0%

Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.